Nektar Therapeutics (NKTR) Current Assets (2016 - 2025)
Historic Current Assets for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $281.4 million.
- Nektar Therapeutics' Current Assets fell 178.86% to $281.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $281.4 million, marking a year-over-year decrease of 178.86%. This contributed to the annual value of $261.3 million for FY2024, which is 2098.84% down from last year.
- Per Nektar Therapeutics' latest filing, its Current Assets stood at $281.4 million for Q3 2025, which was down 178.86% from $186.6 million recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' Current Assets registered a high of $1.1 billion during Q1 2021, and its lowest value of $186.6 million during Q2 2025.
- In the last 5 years, Nektar Therapeutics' Current Assets had a median value of $441.1 million in 2023 and averaged $526.5 million.
- In the last 5 years, Nektar Therapeutics' Current Assets crashed by 3942.85% in 2023 and then plummeted by 178.86% in 2025.
- Quarter analysis of 5 years shows Nektar Therapeutics' Current Assets stood at $795.6 million in 2021, then crashed by 31.37% to $546.0 million in 2022, then tumbled by 39.43% to $330.7 million in 2023, then fell by 20.99% to $261.3 million in 2024, then grew by 7.68% to $281.4 million in 2025.
- Its last three reported values are $281.4 million in Q3 2025, $186.6 million for Q2 2025, and $229.9 million during Q1 2025.